|
Imanishi Naoko
Department University Hospital General Thoracic Surgery, Clinical Departments Position |
|
| Article types | case reports |
| Language | English |
| Peer review | Peer reviewed |
| Title | Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report. |
| Journal | Formal name：Case reports in oncology Abbreviation：Case Rep Oncol ISSN code：/16626575 |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 9(3),565-567頁 |
| Author and coauthor | Kuwata Taiji, Yoneda Kazue, Kobayashi Kenichi, Oyama Rintarou, Matumiya Hiroki, Shinohara Shuichi, Takenaka Masaru, Oka Soichi, Chikaishi Yasuhiro, Imanishi Naoko, Kuroda Koji, Tanaka Fumihiro |
| Publication date | 2016/09 |
| Summary | Tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR) may achieve long-term survival in selected cases with advanced non-small cell lung cancer harboring activating mutations in the EGFR gene, but a cured case has not been reported yet. Here, we present the first case of EGFR-mutated lung adenocarcinoma cured with an EGFR-TKI, as the 75-year-old Japanese man has achieved complete response with gefitinib treatment and has survived without tumor 10 years after termination of gefitinib treatment. |
| DOI | 10.1159/000449371 |
| PMID | 27790122 |